AMBARELLA INC(NASDAQ:AMBA) stock Fundamental Analysis

Fundamental Rating

AMBA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Semiconductors & Semiconductor Equipment industry. AMBA has a great financial health rating, but its profitability evaluates not so good. AMBA shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

AMBA had positive earnings in the past year.

AMBA had a positive operating cash flow in the past year.

In the past 5 years AMBA always reported negative net income.

Of the past 5 years AMBA 4 years had a positive operating cash flow.

1.2 Ratios

AMBA's Return On Assets of -23.48% is on the low side compared to the rest of the industry. AMBA is outperformed by 82.57% of its industry peers.

AMBA has a worse Return On Equity (-28.41%) than 78.90% of its industry peers.

		Industry Rank	Sector Rank
ROA	-23.48%
ROE	-28.41%
ROIC	N/A

ROA(3y)-17.32%

ROA(5y)-13.28%

ROE(3y)-20.64%

ROE(5y)-15.87%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of AMBA (60.52%) is better than 87.16% of its industry peers.

In the last couple of years the Gross Margin of AMBA has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	60.52%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.61%

GM growth 5Y1.19%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AMBA has more shares outstanding

The number of shares outstanding for AMBA has been increased compared to 5 years ago.

AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 8.99 indicates that AMBA is not in any danger for bankruptcy at the moment.

AMBA has a better Altman-Z score (8.99) than 85.32% of its industry peers.

AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	8.99

ROIC/WACCN/A

WACC11.01%

2.3 Liquidity

AMBA has a Current Ratio of 2.84. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.

AMBA has a Current ratio of 2.84. This is comparable to the rest of the industry: AMBA outperforms 48.62% of its industry peers.

A Quick Ratio of 2.50 indicates that AMBA has no problem at all paying its short term obligations.

With a Quick ratio value of 2.50, AMBA perfoms like the industry average, outperforming 56.88% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.84
Quick Ratio	2.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AMBA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.54%, which is quite impressive.

AMBA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.54% yearly.

Looking at the last year, AMBA shows a very strong growth in Revenue. The Revenue has grown by 25.82%.

The Revenue has been growing slightly by 4.49% on average over the past years.

EPS 1Y (TTM)108.54%

EPS 3Y-64.76%

EPS 5Y-36.54%

EPS Q2Q%145.83%

Revenue 1Y (TTM)25.82%

Revenue growth 3Y-4.97%

Revenue growth 5Y4.49%

Sales Q2Q%62.77%

3.2 Future

Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 105.25% on average per year.

The Revenue is expected to grow by 21.05% on average over the next years. This is a very strong growth

EPS Next Y-112.63%

EPS Next 2Y70.57%

EPS Next 3Y133.08%

EPS Next 5Y105.25%

Revenue Next Year20.8%

Revenue Next 2Y15.88%

Revenue Next 3Y18.44%

Revenue Next 5Y21.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AMBA is valuated quite expensively with a Price/Earnings ratio of 615.86.

Based on the Price/Earnings ratio, AMBA is valued a bit more expensive than 65.14% of the companies in the same industry.

AMBA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.29.

The Forward Price/Earnings Ratio is negative for AMBA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	615.86
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AMBA's earnings are expected to grow with 133.08% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y70.57%

EPS Next 3Y133.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMBA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMBARELLA INC

NASDAQ:AMBA (4/17/2025, 5:51:18 PM)

After market: 43.11 0 (0%)

43.11

-0.49 (-1.12%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)02-26 2025-02-26/amc

Earnings (Next)05-28 2025-05-28/amc

Inst Owners85.09%

Inst Owner Change0%

Ins Owners2.81%

Ins Owner Change-0.99%

Market Cap1.83B

Analysts74

Price Target95.51 (121.55%)

Short Float %4.94%

Short Ratio2.18

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)182.88%

Min EPS beat(2)156.13%

Max EPS beat(2)209.63%

EPS beat(4)4

Avg EPS beat(4)103.1%

Min EPS beat(4)18.46%

Max EPS beat(4)209.63%

EPS beat(8)8

Avg EPS beat(8)69.82%

EPS beat(12)12

Avg EPS beat(12)50.08%

EPS beat(16)16

Avg EPS beat(16)47.29%

Revenue beat(2)2

Avg Revenue beat(2)16.52%

Min Revenue beat(2)2.54%

Max Revenue beat(2)30.49%

Revenue beat(4)2

Avg Revenue beat(4)7.58%

Min Revenue beat(4)-1.84%

Max Revenue beat(4)30.49%

Revenue beat(8)2

Avg Revenue beat(8)3.04%

Revenue beat(12)2

Avg Revenue beat(12)1.47%

Revenue beat(16)6

Avg Revenue beat(16)1.58%

PT rev (1m)0%

PT rev (3m)4.57%

EPS NQ rev (1m)0%

EPS NQ rev (3m)87.38%

EPS NY rev (1m)94.8%

EPS NY rev (3m)94.5%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)6.93%

Revenue NY rev (1m)1.74%

Revenue NY rev (3m)4.27%

Valuation

		Industry Rank	Sector Rank
PE	615.86
Fwd PE	N/A
P/S	7.25
P/FCF	N/A
P/OCF	418.29
P/B	3.3
P/tB	8.89
EV/EBITDA	N/A

EPS(TTM)0.07

EY0.16%

EPS(NY)-0.01

Fwd EYN/A

FCF(TTM)-0.09

FCFYN/A

OCF(TTM)0.1

OCFY0.24%

SpS5.95

BVpS13.06

TBVpS4.85

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-23.48%
ROE	-28.41%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	60.52%
FCFM	N/A

ROA(3y)-17.32%

ROA(5y)-13.28%

ROE(3y)-20.64%

ROE(5y)-15.87%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.61%

GM growth 5Y1.19%

F-Score4

Asset Turnover0.38

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	31.69%
Cap/Sales	3.22%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.84
Quick Ratio	2.5
Altman-Z	8.99

F-Score4

WACC11.01%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)108.54%

EPS 3Y-64.76%

EPS 5Y-36.54%

EPS Q2Q%145.83%

EPS Next Y-112.63%

EPS Next 2Y70.57%

EPS Next 3Y133.08%

EPS Next 5Y105.25%

Revenue 1Y (TTM)25.82%

Revenue growth 3Y-4.97%

Revenue growth 5Y4.49%

Sales Q2Q%62.77%

Revenue Next Year20.8%

Revenue Next 2Y15.88%

Revenue Next 3Y18.44%

Revenue Next 5Y21.05%

EBIT growth 1Y-1.16%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-505.48%

EBIT Next 3Y67.17%

EBIT Next 5Y58.57%

FCF growth 1Y-123.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-84.47%

OCF growth 3YN/A

OCF growth 5YN/A

AMBARELLA INC (AMBA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens